{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-10-09T12:22:42.893970+00:00",
  "news": [
    {
      "title": "Amgen to sell cholesterol drug at 60% discount to cash-paying US patients - Reuters",
      "link": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQY093WGV4Y3o1SmQ5TElWbXNtbUxhYUgyLTNNXzdnTUM4dEphOVZ1ZkNieUNlbGx0SmtNbzRpaWVRY1VnVFpld2RVMU5Xc0E1WjJ6RlVCeDkwQ25kOVlMekI5MGlNaW5UZUN0dVdKWWFfQ0ExMjJIUEIwakxQckd1eFc4YzROWUxwZ1h6T0RsdXFGTXNIQTdXSk1FWUwxOVZkTkdmdW53TlRZdGZMRDE1eHB1MVNoZzMzUExrQ1UxRTJGRGw1dF84V200VQ?oc=5",
      "summary": "<ol><li><a href=\"https://news.google.com/rss/articles/CBMiywFBVV95cUxQY093WGV4Y3o1SmQ5TElWbXNtbUxhYUgyLTNNXzdnTUM4dEphOVZ1ZkNieUNlbGx0SmtNbzRpaWVRY1VnVFpld2RVMU5Xc0E1WjJ6RlVCeDkwQ25kOVlMekI5MGlNaW5UZUN0dVdKWWFfQ0ExMjJIUEIwakxQckd1eFc4YzROWUxwZ1h6T0RsdXFGTXNIQTdXSk1FWUwxOVZkTkdmdW53TlRZdGZMRDE1eHB1MVNoZzMzUExrQ1UxRTJGRGw1dF84V200VQ?oc=5\" target=\"_blank\">Amgen to sell cholesterol drug at 60% discount to cash-paying US patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Reuters</font></li><li><a href=\"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOUWgybXNXRktwaFc0VUdsMVhRSjVLbjgwOHpGNl9aNDZpb0RIRTZneGlyVXFSaVlkS1hOQ2tueFRZelZqN29XeGtFU0NlYy1aaFVzZkRMQ0xLMHZHWlJ0bEF5dGVyRkNmU1JoekRiXzJpZ2pHS2VpQUZJMnFhdVdKRUJCbWdZUXN3UTBGNGs5RFY3QXlFb2k2ZDY4cHRRTmpxMlNJRlV3b0pJOEpWVEFSYTl4QzRQUlQzWmZj?oc=5\" target=\"_blank\">Amgen unveils DTC platform with 60% discount on Repatha, giving US lowest price of G7 nations</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font></li><li><a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxPWkRpS1ROdl9hMEp5dl9hTm9HaEJBR1NEdFJXNmpVbHNjaUUyeExYdDRodVJkREl5Q3ItdWM1aTQyby1tb0VrQjIxUmpFMEx3Z3RoaTkwTkNIcTQ1QU5LVXNHbmtfYWQyWjZ2VEFpNlBYdmJsVk16R0tDY3lKR2lmTl94V0NBVGF4ejdzZ2ZPbVdDVzNWaldyMXhoY9IBoAFBVV95cUxQUnozRC1oUHNMRUt5NnRpUl9xLXplTC10bjVpYmJucHd4WGRUZEVSRUQ0UG5BZnEteWNjNEVJR3R5VnpHRUJycVZGamZFV2wtNnM2UTFKSGt3dk5ROGNpeklQN2U4LTBYNUVyYl9SZzZTSFcyMWluaFdHZWszRjJiYzZqOUVSbWVxNTRRLU5lay1uNmJPNU1BSXZ0dDJzVEhI?oc=5\" target=\"_blank\">Healthy Returns: Amgen joins a growing list of drugmakers selling directly to consumers</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font></li><li><a href=\"https://news.google.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?oc=5\" target=\"_blank\">Amgen Lowers Cholesterol-Medication Price After Trump Call for Price Cuts</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Wall Street Journal</font></li><li><a href=\"https://news.google.com/rss/articles/CBMiswFBVV95cUxQRTZXaGFYWGxzWmFFbm03UFZlOG8zQkt3anpEWE11VXYtN25BLU42bkFlcFNyQXpNanFmbG5XejctSmpUNFNBR2dMZElENGZ4c1puU1VMZFpad3ZqemJzRlVHMl9UMGlLdDYzUTYxZlZRelJjZlRlU2NDQWRITlVadVZNbnpfTURpaGNUenhMU1lZeHNnbjI3d0VTNkJERjlNQVFvRW40S184VHhieWVxSVk5QQ?oc=5\" target=\"_blank\">Pharmalittle: We're reading about Novo Nordisk layoffs, an Amgen discount program, and more</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">statnews.com</font></li><li><a href=\"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBMOEVya3pqSzRqZ2R5OEZJNFowbVkwS3p0a1ZqMzNjd1o0ckxfXzg3NzVwMnRBNHB4OF9fb0FVbTNXOFFHQVZCZG9MUHlNYVNCaVNj?oc=5\" target=\"_blank\">Amgen's Repatha discounted 60% via direct line to US patients</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">FirstWord Pharma</font></li><li><a href=\"https://news.google.com/rss/articles/CBMiggFBVV95cUxOMW9sb0NnZWRudHdDc2ZNQ3ZsOXlKRmltQlpLRUVhMkJEQkZGc1ZCQUFjUGFtZUpoUXJzRDdxaXRyUFBTd1NZSUhrSGNoNFFFQTdyZWZaM2VuOWl3T2pXV2VucjRtUHdWcHdtS2xsQTlzWUlYSFEyVDNPVU41Z0NHRWt3?oc=5\" target=\"_blank\">Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60%</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font></li><li><a href=\"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQaXdzbXE0cjkzTHVJWHJtenlXSDlybk42SDJCWnkzYVM0MzdlQlJiVGRkUUQtNkUtcHBxTVlqamVtazJ3WnhyZWlReUdXMDdIZ0FHemxuek5MZmdoWG52Z0l3OGszU2RjMGJsODJJbURPTEswYklJUXY4dFRaR2VvcnNvNGVORExLRE41UmhwRmwwdlRzUzM2YmpxRFhXM1JvU0hZM3NSakdza2Q1dmFMQWh1WXdoOVdqak9iZklDdE10d21FVC1GdjBOX1Y1clI3V1lqd1RKdw?oc=5\" target=\"_blank\">AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PR Newswire</font></li><li><a href=\"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPdllZX1pDRDg4MDdDZHNzWVg0cUZKaWFfNnUtUGQ1S3dnNGFDZmZ4RXc4Q0FWWDRmMXlyRG1GWks3YW5uTHpkckxERlUwSGdYUXhrangyakg3QTBhNFpOMXJMUHlwdElKUnY2UHNWOG1uX3VsSDYwQVJwSzRVbFFCVElYaDZRWEcx?oc=5\" target=\"_blank\">Amgen joins Trump's DTC push, will offer Repatha at 60% list price discount</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font></li></ol>",
      "published": "2025-10-06T16:38:50+00:00",
      "source": "Reuters"
    },
    {
      "title": "David Reese bets his career on the 'hinge moment' for AI at Amgen - Endpoints News",
      "link": "https://news.google.com/rss/articles/CBMie0FVX3lxTE43ZXdwcS1saXMzZjBvX1pxdkYtdG1JaVRXck94Nm5WZzlldkNtLV9VS21zQU1nN1JBTDJ2SUFWQ1prT1RjWi1xNl91YjM5Y0tUWDBsMEhwSmxVd1RUcEF1MWY2XzROSDk4WmpqT2owRmFOenpBZE1XX0ozTQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMie0FVX3lxTE43ZXdwcS1saXMzZjBvX1pxdkYtdG1JaVRXck94Nm5WZzlldkNtLV9VS21zQU1nN1JBTDJ2SUFWQ1prT1RjWi1xNl91YjM5Y0tUWDBsMEhwSmxVd1RUcEF1MWY2XzROSDk4WmpqT2owRmFOenpBZE1XX0ozTQ?oc=5\" target=\"_blank\">David Reese bets his career on the 'hinge moment' for AI at Amgen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
      "published": "2025-10-08T14:00:00+00:00",
      "source": "Endpoints News"
    },
    {
      "title": "Amgen Launches New Direct-To-Consumer Platform - PharmExec",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxOeDdzbTNxdS1aOU01Y09jcGktajV5TkRTM2R4WTJGRUlYOTZ1TXQ3ODJ3dUI4dC1vaVJZVDV6aFpNSk0teDN5bnpZb1RuYVZSd2RyY2EzdTIyOEo5Qko5S0tYVnVaYURHVGtGZFRBRFo4bHBES1pyQlFUZS1UaUJaai1ieHRITG8?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxOeDdzbTNxdS1aOU01Y09jcGktajV5TkRTM2R4WTJGRUlYOTZ1TXQ3ODJ3dUI4dC1vaVJZVDV6aFpNSk0teDN5bnpZb1RuYVZSd2RyY2EzdTIyOEo5Qko5S0tYVnVaYURHVGtGZFRBRFo4bHBES1pyQlFUZS1UaUJaai1ieHRITG8?oc=5\" target=\"_blank\">Amgen Launches New Direct-To-Consumer Platform</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PharmExec</font>",
      "published": "2025-10-08T20:09:16+00:00",
      "source": "PharmExec"
    },
    {
      "title": "Massachusetts Wealth Management Takes $1.82 Million Position in Amgen Inc. $AMGN - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMi0wFBVV95cUxPNVI2SG5pWDRzLVZsZDFfcFgyNUJvUkF0bnlhc2hHdWZ3LWtXTXBER0lteVFqZXhZM3NNRUtSOVRNcmwtQlJQd0FvMjFadTNuMVcyUmZWenFjUEJmUFRzbk9MYWIyQ3JsaWQ3YXdaMVh1TkJxMDNHTEFVV1VOcXVIWnFTSUtQeXc0ZDlTLURyRjJ0UC0tZTJRS2NKTjhSQVRTYU1xcmFsTHZWVkg3RmdHVjV4dzlBWFNjT01EME9UNWlDUW5lM0hNdEhrNk9ETnpESlJz?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi0wFBVV95cUxPNVI2SG5pWDRzLVZsZDFfcFgyNUJvUkF0bnlhc2hHdWZ3LWtXTXBER0lteVFqZXhZM3NNRUtSOVRNcmwtQlJQd0FvMjFadTNuMVcyUmZWenFjUEJmUFRzbk9MYWIyQ3JsaWQ3YXdaMVh1TkJxMDNHTEFVV1VOcXVIWnFTSUtQeXc0ZDlTLURyRjJ0UC0tZTJRS2NKTjhSQVRTYU1xcmFsTHZWVkg3RmdHVjV4dzlBWFNjT01EME9UNWlDUW5lM0hNdEhrNk9ETnpESlJz?oc=5\" target=\"_blank\">Massachusetts Wealth Management Takes $1.82 Million Position in Amgen Inc. $AMGN</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-10-09T09:19:15+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms - The American Journal of Managed Care® (AJMC®)",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNOWJqUGtjRG9IVGhVOVE1SFgtS0hYQlRab1pxTHJWbTNScFlRQkRoRUNqdF96bEs1RmZURFlNVWg2MElWS2JGUHlzd2N6NFozeE8yQlZFVElhZ21UOEJKdW9EazRnanBud3JqUlAzV3A0RVM1TjlNNVQ4X1lFMnBTRnpCQlBpRTBMMElySk1mUXlRd2RrN3NCYV9zazV4c2pYUW94N0VpSE1tcTByc01SVmNYUDNBLVY0YV9yb3ZFYw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNOWJqUGtjRG9IVGhVOVE1SFgtS0hYQlRab1pxTHJWbTNScFlRQkRoRUNqdF96bEs1RmZURFlNVWg2MElWS2JGUHlzd2N6NFozeE8yQlZFVElhZ21UOEJKdW9EazRnanBud3JqUlAzV3A0RVM1TjlNNVQ4X1lFMnBTRnpCQlBpRTBMMElySk1mUXlRd2RrN3NCYV9zazV4c2pYUW94N0VpSE1tcTByc01SVmNYUDNBLVY0YV9yb3ZFYw?oc=5\" target=\"_blank\">Amgen Direct-to-Patient Program Aims to Expand Access to Evolocumab Amid US Drug Pricing Reforms</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The American Journal of Managed Care® (AJMC®)</font>",
      "published": "2025-10-06T21:09:24+00:00",
      "source": "The American Journal of Managed Care® (AJMC®)"
    },
    {
      "title": "Colorado drug board sets first state pricing limit for Amgen’s Enbrel in 2027 - Endpoints News",
      "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxQcUFUX0xJV0hoS2U2MXE2UWVJZGN6REk4WmVERFAwZ0NUbWszNi1XRHdLbzFoZmo5R0x1SkpyZTZMMEY2S01zVEJHb3NsSTJzY242cGFJSmJHUGtLOTIxOXRTOWdtQnlhWENsMHkzM0JxSWNmNUZRUlluLTVYMEJ6Y1pNZjUtU0E2U3Y1c3pKZ0ktNlhNVTc4d2M4WkJIUlRla0E?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiogFBVV95cUxQcUFUX0xJV0hoS2U2MXE2UWVJZGN6REk4WmVERFAwZ0NUbWszNi1XRHdLbzFoZmo5R0x1SkpyZTZMMEY2S01zVEJHb3NsSTJzY242cGFJSmJHUGtLOTIxOXRTOWdtQnlhWENsMHkzM0JxSWNmNUZRUlluLTVYMEJ6Y1pNZjUtU0E2U3Y1c3pKZ0ktNlhNVTc4d2M4WkJIUlRla0E?oc=5\" target=\"_blank\">Colorado drug board sets first state pricing limit for Amgen’s Enbrel in 2027</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Endpoints News</font>",
      "published": "2025-10-08T17:41:00+00:00",
      "source": "Endpoints News"
    },
    {
      "title": "Global biotech leaders Amgen and Gilead announcing expansions in California, the #1 state for life sciences - CA.gov",
      "link": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxQNkFQNVUxYWlJQU1YZlpBSXFrUEotWnBHU1hEQ0lmcU0wR25nX3hETGkxV2M2UVN5NW5ZNHdjYS03NVAyUTBWVjJIZkRyUmR3cXBfUVFjUHVDWDFhYlZSTEhqTlFyenIyNXphZXcyVzNLMml4dlhxeG1qa1dWck1uY1J0SmdaeW9NQ3JmOHNZcnpBR1V2cVAyaXZIXzcxYkFWR3FyTi01NWtFaGE4WGZtbFRlOEQ2ajFJdGpRQ2FDbnBXd3RwbVZob2lJQzZVQWVXOU9VWkxscw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi1wFBVV95cUxQNkFQNVUxYWlJQU1YZlpBSXFrUEotWnBHU1hEQ0lmcU0wR25nX3hETGkxV2M2UVN5NW5ZNHdjYS03NVAyUTBWVjJIZkRyUmR3cXBfUVFjUHVDWDFhYlZSTEhqTlFyenIyNXphZXcyVzNLMml4dlhxeG1qa1dWck1uY1J0SmdaeW9NQ3JmOHNZcnpBR1V2cVAyaXZIXzcxYkFWR3FyTi01NWtFaGE4WGZtbFRlOEQ2ajFJdGpRQ2FDbnBXd3RwbVZob2lJQzZVQWVXOU9VWkxscw?oc=5\" target=\"_blank\">Global biotech leaders Amgen and Gilead announcing expansions in California, the #1 state for life sciences</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CA.gov</font>",
      "published": "2025-09-15T07:00:00+00:00",
      "source": "CA.gov"
    },
    {
      "title": "Amgen Hops on DTC Train To Offer Repatha at 60% Discount - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMikwFBVV95cUxNdkQ1aEZWOTdPMVpnQThOVmY5T0xLdWlTcU8yYXJHOTE3Tk50RHdyaU5SdnlHUTNKcjdUVU1GbW9OTkZIWEZibXlPbjFReTZzbndRY0NJVFNCNWJ5Sm9JMjVCdGhqMEl5NHc5VnpuQlhxa1NycFp1VE55RzhJYzczaV9NU0VxTVU5aXlqbkk3V2IzZnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMikwFBVV95cUxNdkQ1aEZWOTdPMVpnQThOVmY5T0xLdWlTcU8yYXJHOTE3Tk50RHdyaU5SdnlHUTNKcjdUVU1GbW9OTkZIWEZibXlPbjFReTZzbndRY0NJVFNCNWJ5Sm9JMjVCdGhqMEl5NHc5VnpuQlhxa1NycFp1VE55RzhJYzczaV9NU0VxTVU5aXlqbkk3V2IzZnc?oc=5\" target=\"_blank\">Amgen Hops on DTC Train To Offer Repatha at 60% Discount</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-10-07T12:24:20+00:00",
      "source": "BioSpace"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen Launches AmgenNow Direct-to-Consumer Platform to Enhance Product Accessibility - geneonline.com",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxPTHNGUk81UGpwMnlTblZxZTBvRjhlMGNURTJPSHBxREhqUmJxYi0xQ1JUcnhLVXplekRjVUZhdkkzRTFJM3RQQ1lleDZPNmJ4TVVONldPNDRFRTJ4SV9SX0VTQkpYVklrcUxvc2s2XzlYYmhvMnRvczVjcmRBOFhPSlFpdTRYMWFDY1RwUU15SndhLXNDZ0gtUkhPYlNTaElMdXZTZTVDVHEzZ2xOd1ZIYjJR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxPTHNGUk81UGpwMnlTblZxZTBvRjhlMGNURTJPSHBxREhqUmJxYi0xQ1JUcnhLVXplekRjVUZhdkkzRTFJM3RQQ1lleDZPNmJ4TVVONldPNDRFRTJ4SV9SX0VTQkpYVklrcUxvc2s2XzlYYmhvMnRvczVjcmRBOFhPSlFpdTRYMWFDY1RwUU15SndhLXNDZ0gtUkhPYlNTaElMdXZTZTVDVHEzZ2xOd1ZIYjJR?oc=5\" target=\"_blank\">Amgen Launches AmgenNow Direct-to-Consumer Platform to Enhance Product Accessibility</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">geneonline.com</font>",
      "published": "2025-10-08T21:06:00+00:00",
      "source": "geneonline.com"
    },
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Amgen Confirms Launch Of First US Eculizumab Rival - insights.citeline.com",
      "link": "https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi4AFBVV95cUxQVHFOTU9KXzdESTJJc2dLZFF0Q1RMYTFoT3JHeElVd1pxUEdqbDRzdTZkZmQ3eWJZYmpGb1BLMTB6UVctcHVMLWUwNkluT280b215TDNBaFFranlMbll1S2w3QnlJWjFPNDVQZ3ZObmtfZlUxcXZJWEdIaU45Ym1heWJfWUpQTEtZRDNEY281UmprYkZab2RhS05HaUhRTjltZXZ6RG1SRnNlZzRHb05Yc2IwSWRlZHNKZzM1NWF5dzBxbTV2Zlo0blFBU291SkRSUU9QSl91dVJzRVFWakRHNA?oc=5\" target=\"_blank\">Amgen Confirms Launch Of First US Eculizumab Rival</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">insights.citeline.com</font>",
      "published": "2025-03-05T08:00:00+00:00",
      "source": "insights.citeline.com"
    },
    {
      "title": "Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwwFBVV95cUxONkt3YUVEeUpwTU5LYVgtaTk2THhoMEt3ZUliWC1sWmhTTGR4M0hwaVpFMEFla01mUTdxbGVueWNGVThVT3U1T3R2NTQwaEkxeEI5MjRPMzVQUlhaU3hKNVVqQmFFY3BMQ2c3enphdTVLVy1Wb3dTb0l4Rnk3czFVTVFZbUdvVVJwa1I4Z3FDOFByVDZIV21Ccnk5VTd5U3VtNHhuVDdQUldHNm81YnZ6MHFReDBJNmk1S3BucTJhUlplcnc?oc=5\" target=\"_blank\">Amgen settles Prolia patent suit with Celltrion, teeing up potential biosimilar launch in June</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-01-28T08:00:00+00:00",
      "source": "Fierce Pharma"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-10-08",
      "close": 294.6199951171875
    },
    "history": [
      {
        "date": "2025-09-30",
        "close": 282.20001220703125
      },
      {
        "date": "2025-10-01",
        "close": 298.5
      },
      {
        "date": "2025-10-02",
        "close": 297.3999938964844
      },
      {
        "date": "2025-10-03",
        "close": 297.8900146484375
      },
      {
        "date": "2025-10-06",
        "close": 294.1199951171875
      },
      {
        "date": "2025-10-07",
        "close": 295.5400085449219
      },
      {
        "date": "2025-10-08",
        "close": 294.6199951171875
      }
    ],
    "name": "Amgen Inc."
  }
}